Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Sandu Pharmaceuticals

BSE: 524703|ISIN: INE751D01014|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 23, 15:45
37.35
-0.05 (-0.13%)
VOLUME 2,410
Sandu Pharmaceuticals is not listed on NSE
Announcements on Sandu Pharma

14th-Feb-2018 18:54Source: BSE

Sandu Pharmaceuticals- Unaudited Financial Results For The Quarter Ended 31St December 2017

Unaudited Financial Results for the Quarter ended 31st December 2017

27th-Jan-2018 11:45Source: BSE

Sandu Pharmaceuticals- Intimation About The Board Meeting To Be Held On 14Th Feb 2018.

Intimation about the Board Meeting to be held on 14th Feb 2018.

11th-Jan-2018 11:42Source: BSE

Sandu Pharmaceuticals- Statement Of Investors Grievance For The Q Ended 31St December 2017.

Statement of Investors Grievance for the Q ended 31st December 2017.

9th-Jan-2018 15:27Source: BSE

Sandu Pharmaceuticals- Shareholding for the Period Ended December 31, 2017

Sandu Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly

14th-Dec-2017 23:43Source: BSE

Sandu Pharmaceuticals- Financial Results For The Quarter And Half Year Ended 30Th September 2017

Financial results for the quarter and half year ended 30th September 2017

11th-Nov-2017 11:14Source: BSE

Sandu Pharmaceuticals- Intimation Of The Board Meeting To Be Held On Thursday,14Th December 2017 To Approve Unaudited Financial Results For The Quarter Ended 30Th September 2017.

We would like to inform you that a Meeting of the Board of Directors of the Company will be held on Thursday, the 14th day of December, 2017 at 5.00 p.m at the Corporate Office of the Company at Sandu...

23rd-Oct-2017 12:43Source: BSE

Sandu Pharmaceuticals- Outcome of Board Meeting

Outcome of the 3rd Board Meeting for the FY 2017-18 held on Monday 23rd October 2017

20th-Oct-2017 11:21Source: BSE

Sandu Pharmaceuticals- Financial Results For The Quarter Ended 30Th June 2017 As Per Schedule III Format Of Companies Act 2013

Financial Results for the Quarter ended 30th June 2017 as per Schedule III format of Companies Act 2013

19th-Oct-2017 13:03Source: BSE

Sandu Pharmaceuticals- Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

17th-Oct-2017 10:54Source: BSE

Sandu Pharmaceuticals- Updates

Annexure I Statement on Impact of Audit Qualification for the year ended 31st March 2017.

1 2 3 4 5 Next >>
Quick Links for Sandu Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.